TY - JOUR
T1 - 1,550 nm Erbium-Doped and 1,927 nm Thulium Nonablative Fractional Laser System
T2 - Best Practices and Treatment Setting Recommendations
AU - Friedman, Paul M.
AU - Dover, Jeffrey S.
AU - Chapas, Anne
AU - Rahman, Zakia
AU - Ross, Edward V.
AU - Kilmer, Suzanne L.
AU - Roberts, Wendy E.
AU - Sodha, Pooja
AU - Stimmel, Julie B.
AU - Moncrief, Mary Beth C.
AU - Waibel, Jill S.
N1 - Funding Information:
Supported by Solta Medical Inc. P. M. Friedman and Waibel have served on the advisory board for Solta Medical, Inc, and J. S. Dover, A. Chapas, Z. Rahman, E. V. Ross, S.L. Kilmer, W. E. Roberts, and P. Sodha have served as consultants for Solta Medical, Inc.
Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/2/1
Y1 - 2022/2/1
N2 - BACKGROUND The Fraxel Dual laser system (Solta Medical, Inc., Bothell, WA) contains a 1,550 and 1,927 nm wavelength single handpiece with different indications for each wavelength. OBJECTIVE To discuss treatment setting recommendations and best practices for select on-label and investigational applications of the 1,550 and 1,927 nm dual laser system. MATERIALS AND METHODS Eight board-certified dermatologists with 10 or more years of experience with the 1,550 and 1,927 nm laser system completed an online survey about their clinical experience with the system and then participated in a roundtable to share clinical perspectives and best practices for using the laser system. RESULTS For all Fitzpatrick skin types, treatment recommendations were described for selected approved indications for the 1,550 and 1,927 nm laser system, including both lasers in combination. Treatment recommendations were also reached for investigational applications with the 1,550 nm laser and 1,927 nm laser. Best practices for using the lasers during the treatment session to achieve optimal outcomes and decrease the post-treatment recovery time were compiled. CONCLUSION The 1,550 and 1,927 nm dual laser system is effective for a wide range of aesthetic and therapeutic applications, on and off the face and across all Fitzpatrick skin types.
AB - BACKGROUND The Fraxel Dual laser system (Solta Medical, Inc., Bothell, WA) contains a 1,550 and 1,927 nm wavelength single handpiece with different indications for each wavelength. OBJECTIVE To discuss treatment setting recommendations and best practices for select on-label and investigational applications of the 1,550 and 1,927 nm dual laser system. MATERIALS AND METHODS Eight board-certified dermatologists with 10 or more years of experience with the 1,550 and 1,927 nm laser system completed an online survey about their clinical experience with the system and then participated in a roundtable to share clinical perspectives and best practices for using the laser system. RESULTS For all Fitzpatrick skin types, treatment recommendations were described for selected approved indications for the 1,550 and 1,927 nm laser system, including both lasers in combination. Treatment recommendations were also reached for investigational applications with the 1,550 nm laser and 1,927 nm laser. Best practices for using the lasers during the treatment session to achieve optimal outcomes and decrease the post-treatment recovery time were compiled. CONCLUSION The 1,550 and 1,927 nm dual laser system is effective for a wide range of aesthetic and therapeutic applications, on and off the face and across all Fitzpatrick skin types.
UR - http://www.scopus.com/inward/record.url?scp=85124056500&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124056500&partnerID=8YFLogxK
U2 - 10.1097/DSS.0000000000003321
DO - 10.1097/DSS.0000000000003321
M3 - Article
C2 - 35050945
AN - SCOPUS:85124056500
VL - 48
SP - 195
EP - 200
JO - Dermatologic Surgery
JF - Dermatologic Surgery
SN - 1076-0512
IS - 2
ER -